Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T12908 |
SIBA
5'-Deoxy-5'-isobutylthioadenosine,5'-Isobutylthioadenosine,5ˊ-异丁硫基-5ˊ-脱氧腺苷 |
Nucleoside Antimetabolite/Analog; HSV | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Microbiology/Virology |
SIBA (5'-Deoxy-5'-isobutylthioadenosine) 是 SAH 的合成类似物,可作为 S-腺苷甲硫氨酸介导的甲基转移的抑制剂。它干扰多种酶活性,可逆地阻断单纯疱疹病毒 1 型病毒的繁殖。 | |||
T4996 |
Atosiban
阿托西班,RWJ22164,RW22164 |
Oxytocin Receptor; Vasopressin Receptor | Endocrinology/Hormones; GPCR/G Protein |
Atosiban (RW22164) 是一种脱氨基催产素类似物,是一种九肽,也是竞争性的催产素受体拮抗剂。它是一种宫缩抑制剂,可用于自发早产的研究。 | |||
T5148 |
Atosiban acetate
RW22164,Atosiban acetate (90779-69-4 free base),RWJ22164,醋酸阿托西班 |
Oxytocin Receptor; Vasopressin Receptor | Endocrinology/Hormones; GPCR/G Protein |
Atosiban acetate (RW22164) 是一种脱氨基催产素类似物,是一种九肽,也是竞争性的催产素受体拮抗剂。它是一种宫缩抑制剂,可用于自发早产的研究。 | |||
T70570 |
Erlosiban
|
||
Erlosiban, also known as OBE001, is a novel, orally active nonpeptide oxytocin receptor antagonist under development for the treatment of preterm labor and improvement in embryo implantation and pregnancy rate in assisted reproductive technology (ART). | |||
T16736 |
Retosiban
GSK 221149,GSK 221149A |
Others | Others |
Retosiban is an effective and selective oxytocin antagonist (Ki: 0.65 nM). | |||
T69504 |
Barusiban
|
||
Barusiban is an oxytocin receptor antagonist. | |||
T11502 |
Epelsiban
GSK 557296 |
Others | Others |
Epelsiban is a selective and orally bioavailable oxytocin receptor antagonist (pKi: 9.9 for human oxytocin receptor). | |||
T31647 |
Epelsiban besylate
GSK-557296B,GSK557296B |
||
Epelsiban Besylate is an oral drug that is a highly selective anamol oxytocin receptor antagonist. |